Researchers have developed a long-acting weekly injection that delivers steady doses of levodopa and carbidopa, potentially transforming care for Parkinson’s disease.

A progressive neurological disorder affecting 10 million people globally, Parkinson’s can cause disruptive symptoms such as ...

In my sixth year of Parkinson's, cognitive changes leave me wondering how much of this decline is due to the disease and how ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

July 9 (UPI) -- A common virus once thought harmless to humans might be linked to Parkinson's disease, a new study says. The ...

People with Parkinson’s often stay silent about their diagnosis. Here’s what drives that silence and why understanding it ...

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

A study links living near golf courses to higher Parkinson's risk, with strongest association found in those one to three ...